Matthew Bennett

Matthew Bennett

Baker & McKenzie LLP


Matthew is an associate in the Corporate team in Baker McKenzie's London office. He is a member of the Firm's M&A Practice Group, as well as its Consumer Goods & Retail (CG&R) Industry Group. Matthew was seconded to BP's Integrated Supply and Trading division based in Canary Wharf, London for six months in 2017.

Practice Focus

Matthew's practice focuses on cross-border and domestic M&A and joint ventures, as well as advising on intra-group reorganisations and providing corporate governance and maintenance advice, primarily for clients active in the consumer and pharmaceutical sectors.

Representative Legal Matters

  • Advised Puig on its acquisition of a majority stake in Charlotte Tilbury, the iconic British luxury makeup and skincare brand.

  • Advised Unilever on its acquisition of GlaxoSmithKline's Health Food Drinks portfolio in India, Bangladesh and 20 other predominantly Asian markets.

  • Advised Unilever on its acquisition of the home and personal care business of Quala in Latin America.

  • Advised Unilever on the disposal of its Bertolli branded pasta sauces, pesto and mayonnaise business in Continental Europe to Enrico-Glasbest, a Dutch manufacturer and supplier of premium and speciality food products.

  • Advised Unilever on the divestment of its direct application laundry business in Central America to Industria La Popular, a Guatemalan-based home and personal care company.

  • Advised Embracer Group on its USD 137.2 million acquisition of Flying Wild Hog, a developer of PC and console games, through its subsidiary Koch Media, and its USD 765 million of Easybrain Limited, a leading mobile games developer with a core focuson advertising-based puzzle and logic games.

  • Advised Siemens on its acquisition of Process Systems Enterprise Limited, a technology-leading global supplier of software and services for advanced process modelling.

  • Advised McDonald's on multiple transactions in the UK.

  • Advised Novo Nordisk in connection with its acquisition of a UK based biotechnology firm, Ziylo Ltd, with a potential value of USD 800 million.

  • Advised a pharmaceutical industry client on the design and implementation of new board and governance structures across its EMEA group companies.


  • England & Wales (2017)


  • University of Law (LPC) (2015)
  • University of Law (GDL) (2014)
  • University of Southampton (BA History) (2013)


  • English